or Try an Advanced Search...

    Technical Analysis for BCTX - BriaCell Therapeutics Corp.

    Grade Last Price % Change Price Change
    F 1.09 -4.39% -0.05
    BCTX closed down 4.39 percent on Monday, July 1, 2024, on 46 percent of normal volume.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical BCTX trend table...
    Date Alert Name Type % Chg
    1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
    MACD Bullish Signal Line Cross Bullish 0.00%
    Wide Bands Range Expansion 0.00%
    Wide Bands Range Expansion -4.39%
    Oversold Stochastic Weakness -4.39%
    180 Bearish Setup Bearish Swing Setup 4.81%
    Boomer Sell Setup Bearish Swing Setup 4.81%
    NR7 Range Contraction 4.81%
    Narrow Range Bar Range Contraction 4.81%
    Older End-of-Day Signals for BCTX ...

       Recent Intraday Alerts

    Alert Time
    Down 5% about 8 hours ago
    Down 3% about 8 hours ago
    Down 2 % about 8 hours ago
    Down 1% about 8 hours ago
    60 Minute Opening Range Breakdown about 8 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    BCTX Chart by TradingView
    Basic chart:

    Profile

    BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing approaches for the management of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Cancer Clinical Medicine Immune System Immunotherapy Oncology Breast Cancer Treatment Of Breast Cancer Immune Checkpoint National Cancer Institute Advanced Breast Cancer

    Is BCTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 3 BriaCell Presents Clinical Efficacy Data at ASCO 2024
    May 30 BriaCell Initiates Patient Enrollment in First-in-Human Study of Bria-OTS™ in Advanced Metastatic Breast Cancer
    May 28 BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS First in Human Study
    May 28 BriaCell signs supply agreement with BeiGene for metastatic breast cancer treatment
    May 24 BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024
    May 24 This BriaCell Therapeutics Insider Increased Their Holding By 55% Last Year
    May 17 BriaCell Therapeutics Announces Closing of $5.0 Million Registered Direct Offering
    May 15 BriaCell falls on $5M stock offering
    May 15 BriaCell Therapeutics Announces Pricing of $5.0 Million Registered Direct Offering
    Apr 24 BriaCell Announces Oral and Poster Presentations at ASCO 2024
    See more BCTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 7.59
    52 Week Low 0.95
    Average Volume 136,226
    200-Day Moving Average 3.58
    50-Day Moving Average 1.67
    20-Day Moving Average 1.29
    10-Day Moving Average 1.18
    Average True Range 0.16
    RSI (14) 37.11
    ADX 31.4
    +DI 12.68
    -DI 23.41
    Chandelier Exit (Long, 3 ATRs) 1.26
    Chandelier Exit (Short, 3 ATRs) 1.44
    Upper Bollinger Bands 1.61
    Lower Bollinger Band 0.97
    Percent B (%b) 0.19
    BandWidth 49.41
    MACD Line -0.17
    MACD Signal Line -0.17
    MACD Histogram 0.0015
    Fundamentals Value
    Market Cap 17.42 Million
    Num Shares 16 Million
    EPS -1.73
    Price-to-Earnings (P/E) Ratio -0.63
    Price-to-Sales 0.00
    Price-to-Book 23.02
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.30
    Resistance 3 (R3) 1.31 1.25 1.27
    Resistance 2 (R2) 1.25 1.20 1.25 1.25
    Resistance 1 (R1) 1.17 1.16 1.14 1.16 1.24
    Pivot Point 1.11 1.11 1.10 1.11 1.11
    Support 1 (S1) 1.03 1.06 1.00 1.02 0.94
    Support 2 (S2) 0.97 1.02 0.97 0.93
    Support 3 (S3) 0.89 0.97 0.92
    Support 4 (S4) 0.88